Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 21 studies | 40% ± 15% | |
classical monocyte | 18 studies | 33% ± 13% | |
monocyte | 10 studies | 26% ± 9% | |
conventional dendritic cell | 4 studies | 32% ± 12% | |
macrophage | 3 studies | 24% ± 4% | |
dendritic cell | 3 studies | 32% ± 13% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 3 studies | 20% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 675.66 | 577 / 578 | 55% | 2.63 | 635 / 1155 |
breast | 77% | 116.74 | 352 / 459 | 67% | 1.67 | 752 / 1118 |
brain | 55% | 88.44 | 1447 / 2642 | 88% | 4.68 | 620 / 705 |
kidney | 48% | 64.57 | 43 / 89 | 76% | 2.91 | 687 / 901 |
adrenal gland | 90% | 187.51 | 233 / 258 | 14% | 0.27 | 33 / 230 |
bladder | 81% | 130.76 | 17 / 21 | 20% | 1.14 | 100 / 504 |
spleen | 100% | 3274.60 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 12492.73 | 913 / 929 | 0% | 0 | 0 / 0 |
pancreas | 32% | 37.61 | 104 / 328 | 63% | 1.65 | 113 / 178 |
adipose | 95% | 277.69 | 1143 / 1204 | 0% | 0 | 0 / 0 |
thymus | 44% | 42.01 | 285 / 653 | 47% | 0.84 | 285 / 605 |
intestine | 66% | 85.11 | 639 / 966 | 20% | 0.43 | 105 / 527 |
prostate | 67% | 79.00 | 164 / 245 | 14% | 0.19 | 68 / 502 |
stomach | 52% | 73.45 | 186 / 359 | 23% | 0.42 | 67 / 286 |
ovary | 35% | 38.56 | 63 / 180 | 39% | 0.78 | 167 / 430 |
liver | 59% | 96.72 | 134 / 226 | 12% | 0.23 | 49 / 406 |
uterus | 55% | 60.71 | 94 / 170 | 16% | 0.30 | 72 / 459 |
blood vessel | 63% | 114.59 | 846 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 51% | 60.55 | 733 / 1445 | 9% | 0.15 | 16 / 183 |
skin | 19% | 15.92 | 345 / 1809 | 39% | 0.95 | 186 / 472 |
heart | 49% | 61.26 | 420 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 48% | 2.21 | 14 / 29 |
tonsil | 0% | 0 | 0 / 0 | 27% | 0.46 | 12 / 45 |
eye | 0% | 0 | 0 / 0 | 10% | 0.15 | 8 / 80 |
muscle | 5% | 3.42 | 42 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045087 | Biological process | innate immune response |
GO_0007165 | Biological process | signal transduction |
GO_0034144 | Biological process | negative regulation of toll-like receptor 4 signaling pathway |
GO_0140105 | Biological process | interleukin-10-mediated signaling pathway |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0032725 | Biological process | positive regulation of granulocyte macrophage colony-stimulating factor production |
GO_0002220 | Biological process | innate immune response activating cell surface receptor signaling pathway |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0002764 | Biological process | immune response-regulating signaling pathway |
GO_0031665 | Biological process | negative regulation of lipopolysaccharide-mediated signaling pathway |
GO_0051928 | Biological process | positive regulation of calcium ion transport |
GO_0071657 | Biological process | positive regulation of granulocyte colony-stimulating factor production |
GO_0050867 | Biological process | positive regulation of cell activation |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0006952 | Biological process | defense response |
GO_0002283 | Biological process | neutrophil activation involved in immune response |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0001791 | Molecular function | IgM binding |
GO_0032396 | Molecular function | inhibitory MHC class I receptor activity |
GO_0003823 | Molecular function | antigen binding |
Gene name | LILRA2 |
Protein name | Leukocyte immunoglobulin like receptor A2 Leukocyte immunoglobulin like receptor A2 (Leukocyte immunoglobulin-like receptor subfamily A member 2) Leukocyte immunoglobulin-like receptor subfamily A member 2 (CD85 antigen-like family member H) (Immunoglobulin-like transcript 1) (ILT-1) (Leukocyte immunoglobulin-like receptor 7) (LIR-7) (CD antigen CD85h) Leukocyte immunoglobulin-like receptor subfamily A member 2 |
Synonyms | LIR7 ILT1 |
Description | FUNCTION: Part of the innate immune responses against microbial infection . Specifically recognizes a set of N-terminally truncated immunoglobulins that are produced via cleavage by proteases from a range of pathogenic bacteria and fungi, including L.pneumophila, M.hyorhinis, S.pneumoniae, S.aureus and C.albicans . Recognizes epitopes that are in part in the variable region of the immunoglobulin light chains, but requires also the constant region for signaling . Binds to a subset of cleaved IgM, IgG3 and IgG4 molecules, but does not bind cleaved IgA1 . Binding of N-terminally truncated immunoglobulins mediates activation of neutrophils . In monocytes, activation leads to the release of CSF2, CF3, IL6, CXCL8 and CCL3 and down-regulates responses to bacterial lipopolysaccharide (LPS), possibly via down-regulation of TLR4 expression and reduced signaling via TLR4 . In eosinophils, activation by ligand binding leads to the release of RNASE2, IL4 and leukotriene C4 . Does not bind class I MHC antigens . . |
Accessions | ENST00000621611.4 ENST00000616629.1 ENST00000628662.1 A0A087WT41 ENST00000472992.1 ENST00000613573.4 ENST00000618818.4 A0A0G2JMC9 ENST00000391737.3 ENST00000612908.4 ENST00000391738.8 [Q8N149-1] ENST00000251376.7 [Q8N149-2] A0A0G2JMW8 ENST00000439534.5 Q8N149 ENST00000627076.2 ENST00000617409.4 ENST00000617156.1 A0A0D9SFC7 ENST00000620279.4 ENST00000622640.3 ENST00000612001.4 ENST00000251377.7 [Q8N149-1] ENST00000615591.3 A8MZH0 A0A0G2JMR2 ENST00000621721.4 E9PDF4 ENST00000628510.2 ENST00000611940.4 ENST00000631297.1 |